Small cell lung cancer: State-of-the-art therapy in 1996

Chest

Volumn 112, Issue 4 SUPPL., 1997, Pages 251S-258S

  Elias, Anthony D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; PACLITAXEL; TENIPOSIDE; TOPOTECAN; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LUNG SMALL CELL CANCER; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROPHYLAXIS; SKULL IRRADIATION;

EID: 0030876445     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Seifter EJ, Ihde DC. Therapy of small cell lung cancer: a perspective on two decades of clinical research. Semin Oncol 1988; 15:278-99
2. Souhami RL, Beverley PCL, Bobrow LG, et al. The antigens of lung cancer: results of the Second International Workshop on lung cancer antigens. J Natl Cancer Inst 1991; 83:609-12
3. Anderson NE, Rosenblum MK, Graus F, et al. Auto-antibodies in paraneoplastic syndromes with small cell lung cancer. Neurology 1988; 38:1391-98
4. King KA, Hua J, Torday JS, et al. CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides. J Clin Invest 1993; 91:1969-73
5. Frei E III. Combination cancer chemotherapy: presidential address. Cancer Res 1972; 32:2593-2607
6. Osterlind K, Hansen HH, Hansen M, et al. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol 1986; 4:1307-13
7. Pignon JP, Arriagada R, Hide DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327:1618-24
8. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992; 10:890-95
9. Hong WK, Nicaise C, Lawson R, et al. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with cyclophosphamide plus vincristine in the treatment of small cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group. J Clin Oncol 1989; 7:450-56
10. Jett JR, Everson L, Therneau TM, et al. Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized study of the North Central Cancer Treatment Group. J Clin Oncol 1990; 8:33-39